STEPHEN C. FARRELL - 16 Jun 2022 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Role
Director
Signature
/s/ Samuel Gesten as attorney-in-fact for Stephen Farrell
Issuer symbol
STAA
Transactions as of
16 Jun 2022
Net transactions value
$0
Form type
4
Filing time
17 Jun 2022, 18:32:59 UTC
Previous filing
30 Mar 2022
Next filing
12 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STAA Common Stock Options Exercise $0 +355 +5.7% $0.000000 6,567 16 Jun 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STAA Common Stock Options Options Exercise $0 +5,765 $0.000000 5,765 16 Jun 2022 Common Stock 5,765 $62.10 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 16, 2022, STAAR Surgical Company's shareholders approved an increase, effective as of June 2021, in the annual equity grants to non-employee directors, which resulted in the award of an additional 355 shares of restricted stock.
F2 The options vest on the earlier of June 16, 2023 or the Corporation's 2023 Annual Shareholders Meeting, subject to his continued service through the vesting date.

Remarks:

On June 16, 2023, STAAR Surgical Company granted Mr. Farrell, a non-employee director, 5765 options to purchase common stock of the Corporation on his re-election to the Board of Directors.